National PBM Monograph Template

The most commonly reported adverse effects associated with regadenoson include dyspnea, headache, flushing, chest pain, and nausea. Data from the combined analysis of the phase 3 trials showed that the adverse event profile of regadenoson was overall similar to that of adenosine. Although most adverse events were short-lived in both groups, the ... ................
................